Empowering life scientists globally with high-quality biological reagents and tools critical to research, drug discovery and diagnostics

PROGRESS HAPPENS TOGETHER

Inspiring stories from world-leading scientists

PRESS RELEASE

WuXiDiagnostics and Abcam expand existing collaboration to advance companion diagnostics for cancer therapies

PRESS RELEASE

NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research

PRESS RELEASE

Proposed Cancellation of Admission of Ordinary Shares to Trading on AIM and Notice of General Meeting

PRESS RELEASE

Abcam the most Awarded Company at 2022 Industry Awards

WE ARE ABCAM

Abcam in Glassdoor’s Top 5 Best Places to Work in the UK for Second Consecutive Year

INVESTORS

Interim results for the period ended 30 June 2022

Stay up to date with Abcam

NEWS

Keep up to date with our company news

Sign-up to receive the latest corporate updates from Abcam.

EVENTS

Get information on events we are organizing and attending

Including Abcam conferences and webinars.

INVESTORS

Visit the investor centre

For corporate and share information, financial news and events, governance and resources.